Fibroblast growth factor 21 (FGF21) is an obesity- and temperature-related hormone that upregulates the expression of RBM3, which is beneficial as a recombinant treatment and has been tested under different experimental pathological conditions, including stroke. The gene discussed is RBM3; the disease is obesity due to melanocortin 4 receptor deficiency.